GURU.Markets stock price, segment price, and overall market index valuation
The company's share price QT Imaging Holdings Inc.
Shares of QT Imaging, a company developing innovative medical imaging systems, are a venture bet on its technology. Their price trajectory is volatile and depends on FDA approvals and the company's ability to compete with giants like GE and Siemens.
Share prices of companies in the market segment - Cancer women
QT Imaging Holdings develops and manufactures technology for 3D breast imaging without compression or radiation. We've categorized it under "Women's Cancer." The chart below shows how investors value companies offering innovative methods in women's diagnostics.
Broad Market Index - GURU.Markets
QT Imaging Holdings develops and manufactures technology for 3D breast imaging without compression or radiation. We've categorized it under "Women's Cancer." The chart below shows how investors value companies offering innovative methods in women's diagnostics.
Change in the price of a company, segment, and market as a whole per day
QTI - Daily change in the company's share price QT Imaging Holdings Inc.
Daily fluctuations in QT Imaging Holdings, Inc. shares reflect volatility in the medical diagnostics sector. The index demonstrates sensitivity to news about the introduction of its non-invasive breast scanning technology.
Daily change in the price of a set of shares in a market segment - Cancer women
QT Imaging Holdings is developing a new technology for 3D breast imaging without compression or radiation. The oncology diagnostics sector is extremely sensitive to trial results. The chart below shows the volatility in this niche, reflecting the high expectations and risks associated with medical breakthroughs.
Daily change in the price of a broad market stock, index - GURU.Markets
QT Imaging is a medical imaging technology company. Shares of this innovative medtech company are responding to clinical advancements and regulatory decisions, contributing to the overall volatility of the healthcare sector.
Dynamics of market capitalization of the company, segment and the market as a whole over 12 months
Annual dynamics of the company's market capitalization QT Imaging Holdings Inc.
QT Imaging Holdings, Inc.'s year-over-year performance is a story about the development of its unique medical imaging technology. Its 12-month market cap depends entirely on progress in commercializing its scanner, which does not use ionizing radiation. Success could offer a safer alternative to traditional CT.
Annual dynamics of market capitalization of the market segment - Cancer women
As a company developing new medical imaging technology, QT Imaging is betting on innovation. Its performance relative to the sector will reveal the extent to which investors believe in its ability to commercialize its unique technology and secure regulatory approval.
Annual dynamics of market capitalization of broad market stocks, index - GURU.Markets
QT Imaging, with its new breast scanning technology, is attempting to revolutionize diagnostics. Its performance relative to the market is determined by the pending verdict from regulators and the medical community. Success will mean a medical breakthrough and a stock surge; failure will mean oblivion.
Dynamics of market capitalization of the company, segment and the market as a whole for the month
Monthly dynamics of the company's market capitalization QT Imaging Holdings Inc.
QT Imaging is a medical device company developing 3D imaging technology. Its monthly performance reflects progress toward FDA approval and commercialization of its scanner. Clinical data and regulatory engagement updates are key.
Monthly dynamics of market capitalization of the market segment - Cancer women
QT Imaging Holdings develops and manufactures 3D breast imaging technology without ionizing radiation or compression, offering an alternative to mammography. The graph below illustrates the overall trend in the women's health sector, reflecting the search for safer and more comfortable diagnostic methods.
Monthly dynamics of market capitalization of broad market stocks, index - GURU.Markets
Shares of medical companies with breakthrough but not yet fully adopted technology are extremely volatile. The chart below shows the overall risk appetite. Does QT Imaging Holdings move at its own pace, driven by news about the application of its technology?
Dynamics of market capitalization of the company, segment and the market as a whole for the week
Weekly dynamics of the company's market capitalization QT Imaging Holdings Inc.
The weekly performance of QT Imaging reflects the search for safer medical imaging methods. The stock price of this company, which develops non-ionizing radiation scanning technology, responds to data confirming its effectiveness and regulatory decisions.
Weekly dynamics of market capitalization of the market segment - Cancer women
QT Imaging Holdings is developing a new medical imaging technology that does not use ionizing radiation. This chart compares its weekly performance with the medical equipment sector and helps understand how the market perceives the potential of its breakthrough technology compared to traditional CT and MRI.
Weekly dynamics of market capitalization of stocks of the broad market, index - GURU.Markets
QT Imaging develops medical equipment. Demand for its products is driven by medical needs. The chart below will help you determine whether QTI shares are truly a "safe haven" asset, demonstrating stability amid market uncertainty.
Market capitalization of the company, segment and market as a whole
QTI - Market capitalization of the company QT Imaging Holdings Inc.
QT Imaging's market capitalization tells the story of a company developing a new medical imaging technology that doesn't use ionizing radiation. Its speculative chart reflects investors' assessment of this technology's potential to become a safer alternative to CT scanning. Its trajectory tells the story of its long journey to regulatory approval and commercialization.
QTI - Share of the company's market capitalization QT Imaging Holdings Inc. within the market segment - Cancer women
QT Imaging develops medical imaging technology. The company's market capitalization in the medical equipment sector is still small, which is typical for a company with a new technology. The chart below shows how investors assess its potential to change diagnostic standards and compete with industry giants.
Market capitalization of the market segment - Cancer women
QT Imaging is a company developing innovative medical imaging technology without the use of ionizing radiation. The chart below shows the market capitalization of the medical equipment sector. Its dynamics serve as a backdrop for the company's efforts to offer a safer alternative to traditional methods such as mammography.
Market capitalization of all companies included in a broad market index - GURU.Markets
QT Imaging develops new technology for medical imaging. The market capitalization of these companies is a bet that their devices will be able to "see" diseases better than existing methods. Their performance on the overall chart reflects how investors assess the potential of these new "eyes" for medicine.
Book value capitalization of the company, segment and market as a whole
QTI - Book value capitalization of the company QT Imaging Holdings Inc.
QT Imaging's book value is its equity and patents for innovative 3D breast ultrasound scanning technology that doesn't use ionizing radiation. This is real, science-intensive capital for safer cancer diagnostics. How has this medical technology asset changed? The chart below shows its dynamics.
QTI - Share of the company's book capitalization QT Imaging Holdings Inc. within the market segment - Cancer women
QT Imaging is developing new medical imaging technology. The chart shows the share of its R&D and manufacturing assets, reflecting the physical foundation upon which it builds equipment for safer and more accurate diagnostics.
Market segment balance sheet capitalization - Cancer women
QT Imaging, developing new scanning technology, has a capital-intensive R&D business. This requires owning laboratories and prototypes. The BCap_Seg chart for the medical equipment sector shows how expensive it is to create innovative diagnostic systems.
Book value of all companies included in the broad market index - GURU.Markets
QT Imaging's assets are not X-ray machines, but rather its technology and manufactured scanners for obtaining 3D breast images without compression or ionizing radiation. Its balance sheet reflects its patents and manufacturing capabilities. The chart shows the net worth of this innovator in women's health.
The ratio of market capitalization to book capitalization of a company, segment, and the market as a whole
Market capitalization to book capitalization ratio - QT Imaging Holdings Inc.
QT Imaging develops new medical imaging technology. Its balance sheet consists of its patents and equipment prototypes. Its market capitalization reflects the bet that its technology will be safer and more effective than existing methods, such as mammography. The chart reflects hopes for a medical breakthrough.
Market to book capitalization ratio in a market segment - Cancer women
QT Imaging Holdings is developing a new medical imaging technology for breast cancer diagnosis that does not use ionizing radiation. Its evaluation in the chart is based on its potential to become a safer and more affordable alternative to mammography.
Market to book capitalization ratio for the market as a whole
QT Imaging Holdings, Inc. develops innovative medical imaging equipment. The company's value is determined by its unique technology and patents. This chart shows the premium investors are willing to pay for breakthrough medical technology compared to average market valuations.
Debts of the company, segment and market as a whole
QTI - Company debts QT Imaging Holdings Inc.
QT Imaging, a company developing a new radiation-free medical imaging technology, is in the commercialization stage. The capital is being used to bring the scanners to market. This chart shows how the MedTech startup is funding its innovations, aiming to offer a safer alternative to traditional methods like CT.
Market segment debts - Cancer women
QT Imaging Holdings is developing a new medical imaging technology. As with any early-stage medical device company, bringing the product to market requires significant capital. This chart illustrates the company's reliance on equity capital to fund its clinical trials and commercialization.
Market debt in general
Debt to book value of the company, segment and market as a whole
The company's debt to book capitalization ratio QT Imaging Holdings Inc.
QT Imaging Holdings is developing a new medical imaging technology for breast cancer diagnostics that does not use ionizing radiation. This chart shows the company's reliance on debt to complete clinical trials and bring its innovative technology to market, which is a measure of its financial risk.
Market segment debt to market segment book capitalization - Cancer women
QT Imaging Holdings is developing a new medical imaging technology that does not use ionizing radiation, making it a safer alternative to CT scans. The chart shows the debt burden in the medical equipment sector, providing context for assessing how the company is financing the launch of its innovative, yet capital-intensive, technology.
Debt to book value of all companies in the market
QT Imaging Holdings, Inc. is developing a new medical imaging technology that requires significant investment in R&D, clinical trials, and approvals. This chart shows the overall debt burden in the market. It allows one to assess how the MedTech company finances its innovations and how its debt strategy compares to the industry.
P/E of the company, segment and market as a whole
P/E - QT Imaging Holdings Inc.
QT Imaging Holdings is developing a new medical imaging technology that does not use ionizing radiation. This chart shows how the market views its potential alternative to traditional methods such as mammography. This assessment is based on the technology's potential to be safer and more informative.
P/E of the market segment - Cancer women
Medical imaging, where QT Imaging is developing new technology, is an innovative sector. This chart shows the average rating for medical device companies. It helps to understand that QT Imaging is evaluated based on its potential to offer a safer alternative to traditional mammography, a huge market.
P/E of the market as a whole
QT Imaging is a company developing a new medical imaging technology for diagnosing breast cancer without the use of radiation. Its valuation is a pure bet on the success of this technology. It is not tied to the general economic cycles reflected here, but depends entirely on the results of clinical trials and regulatory approval.
Future P/E of the company, segment and market as a whole
Future (projected) P/E of the company QT Imaging Holdings Inc.
This chart for QT Imaging Holdings, Inc., a company developing innovative medical imaging technology, shows market expectations for the future adoption of its equipment. It reflects investor confidence that its Ξ±ΞΊΟινοβολίαΟ-free method will become a sought-after alternative to traditional mammography.
Future (projected) P/E of the market segment - Cancer women
QT Imaging Holdings develops and markets 3D ultrasound technology for breast imaging without compression or radiation, as an alternative to mammography. The chart shows forecasts for the medical equipment sector. This helps assess the market's confidence in QT Imaging's ability to change breast cancer screening standards and achieve widespread adoption.
Future (projected) P/E of the market as a whole
QT Imaging Holdings, Inc. is developing radiation-free 3D breast imaging technology. This innovative approach to breast cancer diagnostics is a key component of QT Imaging. This overall risk appetite chart shows how willing investors are to invest in MedTech startups seeking to transform existing diagnostic standards.
Profit of the company, segment and market as a whole
Company profit QT Imaging Holdings Inc.
QT Imaging Holdings is developing a new technology for 3D breast imaging without compression or radiation. While still in the commercialization stage, the company is incurring losses. This chart shows the financial trajectory of the company, which aims to change the standard of breast cancer diagnosis with its breakthrough technology.
Profit of companies in the market segment - Cancer women
QT Imaging Holdings is developing a new medical imaging technology that uses low-frequency sound waves instead of X-rays. This graph, which shows the sector's profitability, demonstrates the importance of safety in diagnostics. Their breast imaging system aims to offer women a safer and more comfortable alternative to mammography.
Overall market profit
QT Imaging Holdings is developing and commercializing a new medical imaging technology that does not use ionizing radiation, making it a safe alternative for breast cancer screening. Success depends on physician acceptance of the technology. Overall economic stability, as illustrated by the graph, facilitates innovation in healthcare.
Future (predicted) profit of the company, segment and market as a whole
Future (projected) profit of the company QT Imaging Holdings Inc.
QT Imaging Holdings is developing an innovative 3D ultrasound technology for breast imaging that does not use ionizing radiation like mammography. This graph reflects analysts' expectations for the commercialization of this technology and its acceptance by the medical community as a new standard in breast cancer diagnostics.
Future (predicted) profit of companies in the market segment - Cancer women
QT Imaging Holdings is developing and commercializing a new radiation-free medical imaging technology for breast cancer diagnosis. Growth depends on the adoption of its technology. This chart for the medical device sector illustrates the overall expectations for the adoption of safer and more effective diagnostic tools.
Future (predicted) profit of the market as a whole
QT Imaging Holdings is developing a new medical imaging technology. The company's success depends on regulatory approval and the implementation of the technology in clinics. The overall economic forecast presented here affects hospital budgets and their willingness to invest in expensive new medical equipment.
P/S of the company, segment and market as a whole
P/S - QT Imaging Holdings Inc.
QT Imaging Holdings is developing innovative 3D breast imaging technology without radiation or compression. This chart is important for a company entering the market. It shows how investors assess its revenue potential, betting that its technology will become a safer and more comfortable alternative to mammography.
P/S market segment - Cancer women
QT Imaging Holdings is developing and commercializing a new medical imaging technology that does not use ionizing radiation, which is particularly important for women's health. The company's revenue will depend on the adoption of its scanners. This chart shows the average valuation in the sector, helping to understand how the market views the potential of this breakthrough diagnostic technology.
P/S of the market as a whole
QT Imaging is a company developing a new medical imaging technology (breast scanning) that does not use ionizing radiation like mammography. This chart, which reflects revenue estimates for traditional companies, highlights that QTI's value reflects investors' faith in the potential of its technology to change the standard of breast cancer diagnosis.
Future P/S of the company, segment and market as a whole
Future (projected) P/S of the company QT Imaging Holdings Inc.
QT Imaging Holdings is a medical technology company developing a new 3D breast imaging technology that uses no radiation or compression. It is a potential alternative to mammography. This chart reflects investors' hopes that its technology will be approved and adopted by the medical community as a new screening standard.
Future (projected) P/S of the market segment - Cancer women
QT Imaging Holdings, Inc. develops and commercializes ultrasound imaging technology for breast imaging, offering a radiation- and compression-free alternative to mammography. This chart shows the average estimated future sales in the medical device sector. It helps understand how the market views the potential of QT Imaging's innovative technology.
Future (projected) P/S of the market as a whole
QT Imaging Holdings is developing and commercializing an innovative breast ultrasound imaging technology that does not use ionizing radiation. This chart shows overall market revenue forecasts. The company's technology could become a safer and more comfortable alternative to traditional mammography, opening up a huge market.
Sales of the company, segment and market as a whole
Company sales QT Imaging Holdings Inc.
This chart shows the revenue of QT Imaging Holdings, a medical technology company developing innovative systems for non-compressive and radiation-free breast imaging. Sales are generated from sales of its scanners to medical institutions. The trend will reflect the market adoption of this new diagnostic technology.
Sales of companies in the market segment - Cancer women
QT Imaging Holdings develops and manufactures 3D ultrasound technology for breast imaging without radiation or compression. This graph illustrates the growth of the medical equipment market. The company's innovative approach has the potential to revolutionize breast cancer screening, offering a safer and more comfortable alternative to mammography and creating a new industry standard.
Overall market sales
QT Imaging Holdings develops innovative technologies for medical imaging, particularly for breast cancer diagnostics. Its success depends on the implementation of this technology in clinics. The overall economic situation, reflected in this chart, influences healthcare budgets and the willingness of medical institutions to purchase new equipment.
Future sales volume of the company, segment and market as a whole
Future (projected) sales of the company QT Imaging Holdings Inc.
QT Imaging is developing a new medical imaging technology for breast cancer diagnostics that does not use ionizing radiation. Future revenues are dependent on regulatory approval and physician acceptance. The chart reflects expectations for this innovative medical technology market.
Future (projected) sales of companies in the market segment - Cancer women
QT Imaging Holdings is developing and commercializing a new radiation-free medical imaging technology for breast cancer diagnostics. This chart shows the forecast for the medical equipment market, where safe and accurate diagnostics of women's health is a priority.
Future (projected) sales of the market as a whole
QT Imaging Holdings develops and manufactures 3D ultrasound technology for breast imaging without compression or radiation. The company's success depends on the acceptance of its technology by the medical community. This graph, reflecting overall healthcare costs, influences clinics' willingness to invest in new diagnostic equipment.
Marginality of the company, segment and market as a whole
Company marginality QT Imaging Holdings Inc.
QT Imaging Holdings is developing and commercializing a new medical imaging technology that does not use ionizing radiation, specifically for breast cancer diagnostics. This chart shows the R&D and commercialization costs of this innovative and safer alternative to traditional methods such as mammography, and its long road to profitability.
Market segment marginality - Cancer women
QT Imaging is a medical technology company developing a new 3D breast imaging technology that uses no radiation or compression. Profitability depends on regulatory approval and acceptance by radiologists. This chart reflects investments in the development and commercialization of this innovative diagnostic tool for women's health.
Market marginality as a whole
QT Imaging Holdings is a medical company developing a new technology for compression- and radiation-free 3D breast imaging based on ultrasound. This technology could become an alternative to mammography. Given this graph, reflecting the current economic climate, QTI is betting on a breakthrough in medical diagnostics. Their success depends on clinical data and regulatory approval.
Employees in the company, segment and market as a whole
Number of employees in the company QT Imaging Holdings Inc.
QT Imaging is developing a new medical imaging technology. As a development-stage company, it has a small team consisting primarily of engineers and scientists. This timeline reflects its current focus on refining the technology and completing clinical trials.
Share of the company's employees QT Imaging Holdings Inc. within the market segment - Cancer women
QT Imaging Holdings develops innovative medical imaging technology that does not use ionizing radiation. This chart reflects its strength in the medical imaging niche. It shows the size of the team of engineers and clinicians working on the commercialization of this breakthrough technology, which is particularly promising for breast imaging.
Number of employees in the market segment - Cancer women
QT Imaging Holdings, Inc. is a company developing and commercializing low-frequency ultrasound technology for breast imaging. This chart shows employment trends in the medical imaging sector. The growing number of engineers here reflects the desire to create a safer and more comfortable alternative to traditional mammography without the use of ionizing radiation.
Number of employees in the market as a whole
QT Imaging Holdings develops innovative technologies for medical imaging. The implementation of its equipment depends on capital expenditures by medical institutions. Overall economic growth, reflected in this chart, supports stable funding for the healthcare system, allowing hospitals and clinics to invest in advanced diagnostic technologies.
Market capitalization per employee (in thousands of dollars) of the company, segment, and market as a whole
Market capitalization per employee (in thousands of dollars) of the company QT Imaging Holdings Inc. (QTI)
QT Imaging Holdings is developing a radiation-free 3D breast scanning technology for cancer detection. It's a MedTech startup. The chart shows that the company's entire market capitalization is based on its technology. The high cost per employee (engineer, scientist) reflects investors' belief that this technology will displace traditional mammography, not current sales.
Market capitalization per employee (in thousands of dollars) in the market segment - Cancer women
QT Imaging Holdings is developing a new medical imaging technology that does not use ionizing radiation, making it safer for imaging procedures such as breast cancer. The company's value is based on the potential of this breakthrough technology. This chart shows how the market values ββits intellectual property.
Market capitalization per employee (in thousands of dollars) for the overall market
QT Imaging Holdings develops low-radiation medical imaging technology for breast cancer diagnosis. The chart shows its valuation in the MedTech sector. The high market capitalization per employee reflects the potential of their technology to become a safer and more affordable alternative to traditional mammography.
Profit per employee (in thousands of dollars) for the company, segment, and market as a whole
Profit per employee (in thousands of dollars) of the company QT Imaging Holdings Inc. (QTI)
QT Imaging is a medical device company developing a new 3D breast imaging technology that doesn't use compression or radiation. It's an R&D company on the road to commercialization. This chart shows the company's capital burn rate: the amount it spends on each engineer and physician during the process of obtaining FDA approval and bringing the device to market.
Profit per employee (in thousands of dollars) in the market segment - Cancer women
QT Imaging is a company developing a new medical imaging technology for breast cancer diagnosis without compression or radiation. This R&D business is in the approval and commercialization stages. This metric (loss per employee) reflects the investment in this breakthrough technology.
Profit per employee (in thousands of dollars) for the market as a whole
QT Imaging is a medical technology company developing a new radiation-free 3D scanning technology for breast cancer diagnostics. It is an R&D company in the commercialization stage and is not profitable. This chart shows the company's capital burn rate: operating loss per engineering team.
Sales to employees of the company, segment and market as a whole
Sales per company employee QT Imaging Holdings Inc. (QTI)
QT Imaging is a medical technology company that has developed an innovative radiation-free 3D breast imaging system. This chart reflects the commercialization of its technology. Increased revenue per employee will indicate the successful adoption of its scanners in clinics and hospitals as a safe alternative to mammography.
Sales per employee in the market segment - Cancer women
QT Imaging (QTI) is developing an innovative breast cancer diagnostic scanner that uses ultrasound rather than X-rays (mammography). This graph shows the revenue (from early sales or partnerships) generated by each employee (engineer, scientist). This measures their early commercial progress in the medtech segment.
Sales per employee for the market as a whole
QT Imaging (QTI) is developing a new 3D breast scanning technology (non-compressive and non-radiating) for cancer diagnosis. The company is in the commercialization phase of its equipment. This chart shows how successfully the company is beginning to generate revenue from sales of its innovative scanners, despite its large R&D and engineering staff.
Short shares by company, segment and market as a whole
Shares shorted by company QT Imaging Holdings Inc. (QTI)
QT Imaging Holdings is developing a new breast imaging technology that doesn't use radiation or compression. The bearish interest shown in this chart is a bet that its technology won't receive FDA approval or convince doctors and insurance companies of its advantages over standard mammography.
Shares shorted by market segment - Cancer women
This reflects investor skepticism about the entire medical technology sector, particularly diagnostics. QT Imaging is developing innovative ultrasound imaging for breast cancer detection. The rise in this chart signals investors' doubts about the industry's ability to quickly implement new, expensive technologies or navigate complex FDA regulatory hurdles.
Shares shorted by the overall market
QT Imaging is an R&D company developing new 3D scanning technology for cancer diagnostics. This chart reflects the overall market pessimism. Investors fear that during the crisis, hospitals will freeze budgets for new, expensive, and not yet widely accepted diagnostic equipment, which will kill commercialization.
RSI 14 indicator for a company, segment, and market as a whole
The company's RSI 14 indicator QT Imaging Holdings Inc. (QTI)
QT Imaging Holdings is developing a new 3D breast scanning technology (QTI) for detecting cancer without compression or radiation. This represents a potential breakthrough in diagnostics. This chart tracks the hype surrounding their technology, showing "overheating" (above 70) on FDA approval news or "oversold" (below 30) pending data.
RSI 14 Market Segment - Cancer women
QT Imaging is a medical technology company. They developed an innovative breast scanner (QTI), which uses non-X-ray (low-frequency) waves to create 3D images. It's an alternative to mammography. This chart measures the overall momentum in the medical imaging sector. It helps assess whether this entire innovative segment is overheated.
RSI 14 for the overall market
QT Imaging (QTI) is a biotech R&D company. Like everyone in its sector, it's critically dependent on this schedule. Market euphoria offers the potential to easily raise hundreds of millions of dollars for research. Market panic risks running out of money before its breakthrough technologies reach patients.
Analyst consensus forecast for the company's share price, the segment, and the market as a whole
Analyst consensus stock price forecast QTI (QT Imaging Holdings Inc.)
QT Imaging (QTI) is developing an innovative 3D ultrasound technology for breast imaging that uses no radiation or compression. This graph shows the average 12-month forecast, reflecting analysts' belief that this technology will receive FDA approval and become a popular alternative to traditional mammography.
The difference between the consensus estimate and the actual stock price QTI (QT Imaging Holdings Inc.)
QT Imaging (QTI) is "MRI without magnets." The medical technology company is developing an ultrasound-based scanner for 3D breast imaging, which is intended to be safer than mammography. This chart shows the upside and downside potential analysts see in the stock. It measures the gap between the price and forecast, reflecting their faith in this breakthrough R&D technology.
Analyst consensus forecast for stock prices by market segment - Cancer women
QT Imaging is a MedTech startup developing "ultrasound 2.0." Its technology uses "quantum" acoustics for 3D imaging of breast cancer without radiation. This chart displays analysts' overall expectations for the *entire* female cancer sector. It shows whether experts believe a breakthrough in diagnostics is possible.
Analysts' consensus forecast for the overall market share price
QT Imaging (QTI) is a medical technology company that wants to "replace" mammograms. They've developed a 3D breast scanner that uses ultrasound (rather than radiation) to detect cancer. This is a bet on diagnostic R&D. This chart shows the overall risk appetite, reflecting the willingness of investors to fund breakthrough, but extremely risky, R&D projects.
AKIMA index of the company, segment and market as a whole
AKiMA Company Index QT Imaging Holdings Inc.
QT Imaging is ultrasound 3.0 for the breast. Their gimmick isn't mammography (an X-ray); it's a new scanner (QT Imaging) that (they claim) uses ultrasound (not radiation) to create a precise 3D map of the breast (for cancer diagnosis). This graph summarizes their rollout history. It reflects their (slow) path to FDA approval and their (uphill) struggle for commercialization.
AKIMA Market Segment Index - Cancer women
QT Imaging (QTI) is dedicated to women's cancer and safety. They've created a breast ultrasound scanner that doesn't compress the breast or use radiation (like mammography). It's a comfortable diagnostic experience. This chart compares their composite index to the sector, showing how their safety technology outperforms the competition.
The AKIM Index for the overall market
QT Imaging is a medtech company that developed a radiation- and compression-free breast ultrasound technology (QTscan). This chart, which reflects the market average, provides context. It helps assess how this innovation in cancer screening compares to overall macroeconomic trends and medical standards.